GENC BILGICLI ET AL.
9 of 9
|
ACKNOWLEDGMENT
[24] C. Yamali, H. I. Gul, A. Ece, P. Taslimi, I. Gulcin, Chem. Biol. Drug Des.
2018, 91, 854.
This study was supported by Research Fund of the Sakarya
[25] F. Erdemir, D. Barut Celepci, A. Aktaş, P. Taslimi, Y. Gök, H.
Karabıyık, İ. Gülçin, J. Mol. Struct. 2018, 1155, 797.
[26] A. Aktaş, P. Taslimi, İ. Gülçin, Y. Gök, Arch. Pharm. Chem. Life Sci.
2017, 350, e201700045.
University, project number: 2018‐2‐7–196.
ORCID
[27] H. I. Gul, E. Mete, P. Taslimi, I. Gulcin, C. T. Supuran, J Enzyme Inhib.
Med. Chem. 2017, 32, 189.
Hayriye Genc Bilgicli
[28] M. Torres‐Naranjo, A. Suárez, G. Gilardoni, L. Cartuche, P. Flores, V.
Morocho, Molecules 2016, 21, 1461.
Parham Taslimi
Busra Akyuz
Burak Tuzun
İlhami Gulcin
[29] H. Teng, L. Chen, T. Fang, B. Yuan, Q. Lin, J. Funct. Foods 2017, 28, 306.
[30] N. Öztaşkın, Y. Çetinkaya, P. Taslimi, S. Göksu, İ. Gülçin, Bioorg. Chem.
2015, 60, 49.
[31] P. Taslimi, C. Caglayan, İ. Gulcin, J. Biochem. Mol. Toxicol. 2017, 31.
[32] B. Tüzün, C. Kaya, J. Bio. Tribo‐Corros. 2018, 4, 69.
[33] E. Hazai, S. Kovács, L. Demkó, Z. Bikádi, Acta Pharm. Hung. 2009, 79, 17.
[34] J. B. Billones, Orient. J. Chem. 2016, 32, 851.
[35] C. Bayrak, P. Taslimi, H. S. Karaman, I. Gulcin, A. Menzek, Bioorg.
Chem. 2019, 85, 128.
REFERENCES
[1] J. Alvarez‐Builla, J. J. Vaquero, J. Barluenga, Modern Heterocyclic
Chemistry. 4 Volume Set, John Wiley & Sons, Whenheim, Germany 2011.
[2] A. R. Katritzky, C. A. Ramsden, J. A. Joule, V. V. Zhdankin, Handbook
of Heterocyclic Chemistry, 3rd ed., Elsevier, The Netherlands,
Amsterdam 2010.
[36] T. Tantimongcolwat, S. Prachayasittikul, V. Prachayasittikul, Spectro-
chim. Acta, Part A 2019, 216, 25.
[37] Y. Tao, Y. Zhang, Y. Cheng, Y. Wang, Biomed. Chromatogr. 2013, 27, 148.
[38] J. Zhen, Y. Dai, T. Villani, D. Giurleo, J. E. Simon, Q. Wu, Bioorg. Med.
Chem. 2017, 25, 5355.
[3] S. J. Kashyap, V. K. Garg, P. K. Sharma, N. Kumar, R. Dudhe, J. K.
Gupta, Med. Chem. Res. 2012, 21, 2123.
[39] G. Wang, M. Chen, J. Qiu, Z. Xie, A. Cao, Bioorg. Med. Chem. Lett.
2018, 28, 113.
[4] A. K. Jain, A. Vaidya, V. Ravichandran, S. K. Kashaw, R. K. Agrawal,
Bioorg. Med. Chem. 2012, 20, 3378.
[40] J. A. Verpoorte, S. Mehta, J. T. Edsall, J. Biol. Chem. 1967, 242, 4221.
[41] M. Boztas, P. Taslimi, M. A. Yavari, I. Gulcin, E. Sahin, A. Menzek,
Bioorg. Chem. 2019, 89, 103017.
[5] A. Bolognese, G. Correale, M. Manfra, A. Lavecchia, E. Novellino, V.
Barone, Org. Biomol. Chem. 2004, 2, 2809.
[6] R. B. Pathak, P. T. Chovatia, H. H. Parekh, Bioorg. Med. Chem. Lett.
2012, 22, 5129.
[42] U. Atmaca, R. Kaya, H. S. Karaman, M. Çelik, İ. Gülçin, Bioorg. Chem.
2019, 88, 102980.
[7] C. Nitsche, V. N. Schreier, M. A. M. Behnam, A. Kumar, R.
Bartenschlager, C. D. Klein, J. Med. Chem. 2013, 56, 8389.
[8] H. Chen, T. Yang, S. Wei, H. Zhang, R. Li, Z. Qin, X. Li, Bioorg. Med.
Chem. Lett. 2012, 22, 7041.
[43] F. Turkan, A. Cetin, P. Taslimi, H. S. Karaman, İ. Gulçin, Arch. Pharm.
Chem. Life Sci. 2019, 352, 1800359.
[44] G. L. Ellman, K. D. Courtney, V. Andres, R. M. Featherstone, Biochem.
Pharmacol. 1961, 7, 88.
[9] M. Sala, A. Chimento, C. Saturnino, I. M. Gomez‐Monterrey, S.
Musella, A. Bertamino, C. Milite, M. S. Sinicropi, A. Caruso, R.
Sirianni, P. Tortorella, E. Novellino, P. Campiglia, V. Pezzi, Bioorg.
Med. Chem. Lett. 2013, 23, 4990.
[45] K. Kucukoglu, H. I. Gul, P. Taslimi, I. Gulcin, C. T. Supuran, Bioorg.
Chem. 2019, 86, 316.
[46] S. Burmaoglu, A. O. Yilmaz, M. F. Polat, R. Kaya, İ. Gulcin, O. Algul,
Bioorg. Chem. 2019, 85, 191.
[10] R. B. Leysk, B. S. Zimenkovsky, D. V. Kaminskyy, A. P. Kryshchyshyn,
D. Ya Havryluk, D. V. Atamanyuk, I. Yu. Subtel’na, D. V. Khyluk,
Biopol. Cell 2011, 27, 107–117.
[47] S. Ökten, M. Ekiz, Ü. M. Koçyiğit, A. Tutar, İ. Çelik, M. Akkurt, F.
Gökalp, P. Taslimi, I. Gülçin, J. Mol. Struct. 2019, 1175, 906.
[48] D. Ozmen Ozgun, H. I. Gul, C. Yamali, H. Sakagami, I. Gulcin, M.
Sukuroglu, C. T. Supuran, Bioorg. Chem. 2019, 84, 511.
[49] S. Kaya, B. Tüzün, C. Kaya, I. B. Obot, J. Taiwan Inst. Chem. Eng. 2016,
58, 528.
[11] D. Pires Gouvea, F. A. Vasconcellos, G. dos Anjos Berwaldt, A. C.
Neto, G. Fischer, R. P. Sakata, W. P. Almeida, W. Cunico, Eur. J. Med.
Chem. 2016, 118, 259.
[12] S. P. Singh, S. S. Parmar, K. Raman, V. I. Stenberg, Chem. Rev. 1981,
81, 175.
[50] C. Hepokur, A. Günsel, M. N. Yarasir, A. T. Bilgiçli, B. Tüzün, G.
Tüzüna, I. Yaylimd, RSC Adv. 2017, 7, 56296.
[13] M. Zengin, H. Genc, P. Taslimi, A. Kestane, E. Guclu, A. Ogutlu, O.
Karabay, I. Gulcin, Bioorg. Chem. 2018, 81, 119.
[51] S. Kaya, B. Tüzün, C. Kaya, Curr. Phys. Chem. 2017, 7, 147.
[14] İ. Gulçin, P. Taslimi, Expert Opin. Ther. Pat. 2018, 28, 541.
[15] P. Taslimi, H. E. Aslan, Y. Demir, N. Oztaskin, A. Maraş, İ. Gulçin, S.
Beydemir, S. Goksu, Int. J. Biol. Macromol. 2018, 119, 857.
[16] I. Gulcin, R. Kaya, A. C. Goren, H. Akincioglu, M. Topal, Z. Bingol, K.
Cetin Çakmak, S. B. Ozturk Sarikaya, L. Durmaz, S. Alwasel, Int. J.
Food Prop. 2019, 22, 1511.
SUPPORTING INFORMATION
Additional supporting information may be found online in the
Supporting Information section.
[17] P. Taslimi, İ. Gulçin, J. Food Biochem. 2018, 42, e12516.
[18] C. T. Supuran, J. Enzyme Inhib. Med. Chem. 2016, 31, 345.
[19] H. Genc, B. Ceken, C. Bilen, Z. Sackes, N. Gencer, O. Arslan, Lett. Org.
Chem. 2017, 14, 80.
How to cite this article: Bilgicli HG, Taslimi P, Akyuz B,
Tuzun B, Gulcin İ. Synthesis, characterization, biological
evaluation, and molecular docking studies of some piperonyl‐
based 4‐thiazolidinone derivatives. Arch Pharm Chem Life Sci.
[20] A. R. Surrey, J. Am. Chem. Soc. 1947, 69, 2911.
[21] M. P. Thakare, P. Kumar, N. Kumar, S. K. Pandey, Tetrahedron Lett.
2014, 55, 2463.
[22] P. D. Neuenfeldt, A. R. Duval, B. B. Drawanz, P. F. Rosales, C. R.
Gomes, C. M. Pereira, W. Cunico, Ultrason. Sonochem. 2011, 18, 65.
[23] R. Abonia, J. Castillo, B. Insuasty, J. Quiroga, M. Sortino, M.
Nogueras, J. Cobo, Arab. J. Chem. 2019, 12, 122.